FDA Inspection
NATCO Pharma LimitedNATCO Pharma Limited – FDA Inspection, Jun 6, 2019
Record Details
This FDA Inspection record concerns NATCO Pharma Limited, with an inspection on June 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ea855f48-56a5-4020-95b4-2e58b1a8caf2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1095772
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of NATCO Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| October 18, 2023 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| June 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NATCO Pharma Limited
- FDA Inspection 1273711 - 2025-06-19
- FDA Inspection 1220533 - 2023-10-18
- FDA Inspection 1137171 - 2019-06-24
- FDA Inspection 1011854 - 2017-01-24
- FDA Inspection 880454 - 2014-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.